Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Pediatrix Medical Group's 3-Year RORE % for the quarter that ended in Mar. 2026 was 839.90%.
The industry rank for Pediatrix Medical Group's 3-Year RORE % or its related term are showing as below:
MEX:MD's 3-Year RORE % is ranked better than 99.01% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 0.195
vs MEX:MD: 839.90
Pediatrix Medical Group (MEX:MD) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Pediatrix Medical Group 3-Year RORE % Related Terms
Pediatrix Medical Group 3-Year RORE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:MD vs SEM, AGL, SGRY: 3-Year RORE % Comparison
For the Medical Care Facilities subindustry, Pediatrix Medical Group's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pediatrix Medical Group 3-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Pediatrix Medical Group's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.
Pediatrix Medical Group (MEX:MD) has a 3-Year RORE % of 839.90 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Pediatrix Medical Group and its competitors. According to the industry distribution chart, Pediatrix Medical Group ranks #6 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 1%.
Is Pediatrix Medical Group's 3-Year RORE % too high?
Pediatrix Medical Group's current 3-Year RORE % is 839.90. The Healthcare Providers & Services industry median 3-Year RORE % is 0.20. Pediatrix Medical Group's value of 839.90 is 430617.9% above this industry median. Based on the distribution chart, Pediatrix Medical Group ranks #6 out of 606 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pediatrix Medical Group has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's 3-Year RORE % compare to SEM and AGL?
According to the Healthcare Providers & Services industry distribution chart, Pediatrix Medical Group ranks #6 out of 606 companies for 3-Year RORE %. This places Pediatrix Medical Group in the top 1% of its industry — outperforming the majority of peers. The industry median 3-Year RORE % is 0.20. Pediatrix Medical Group's value of 839.90 is 430617.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.20, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pediatrix Medical Group's current 3-Year RORE % of 839.90 is 430617.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Pediatrix Medical Group and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pediatrix Medical Group's current 3-Year RORE % is 839.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Pediatrix Medical Group (MEX:MD) has a current 3-Year RORE % of 839.90. The stock's GF Value™ is MXN158.60, compared to a current price of MXN323.00 — trading 103.7% above its estimated fair value. The current 3-Year RORE % is 839.90 and 430617.9% above the Healthcare Providers & Services industry median of 0.20. Pediatrix Medical Group's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Pediatrix Medical Group (MEX:MD), the current 3-Year RORE % is 839.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pediatrix Medical Group (MEX:MD) Overvalued in 2026?
Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued.
The current stock price of MXN323.00 is trading 103.7% above its estimated GF Value™ of MXN158.60.
Key valuation signals for MEX:MD:
3-Year RORE %: 839.90
GF Value™: MXN158.60 vs. price of MXN323.00 (103.7% above fair value)
Industry Position: 430617.9% above the Healthcare Providers & Services median (#6 of 606)
No single metric tells the full story. See the MEX:MD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
59GF Score
Get the complete analysis for MEX:MD
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:MD has been successfully added to your 
